Connecting to SEC EDGAR… PricingSign in
← All filings
Zenas BioPharma, Inc.ZBIO · Nov 6, 4:16 PM ET

Zenas BioPharma files new $200 million at-the-market stock sales program

Zenas BioPharma filed an additional prospectus supplement for up to $200,000,000 of common stock sales through Jefferies LLC, ending its prior program, which had about $46.8 million unsold.

AI-generated summary, checked against the filing. Can contain errors: read the original filing ↗. Not investment advice.